Justice Housing has a wish list of new, unopened items the nonprofit is collecting for Welcome Home Kits for the residents of Cottage Hill Place. People may also contribute toward the purchase of ...

WESTERLY, R.I., Feb. 6, 2025 /PRNewswire/ -- Washington Trust employees recently built and donated 35 "Welcome Home Kits" to benefit Crossroads Rhode Island clients who are transitioning from ...

For those who typically order takeout, meal kits may add more nutritional value ... My 2020 testing journey led to a whole lot of boxes, which was a welcome activity during the lockdown of the ...

"Welcome to Wrexham season 4 has been officially confirmed. The Emmy-winning documentary about the Welsh football (soccer) team owned by Hollywood stars Ryan Reynolds and Rob McElhenney has ...

On a remote island in the Pacific, Will Smith descends into the heart of an active volcano to investigate sounds beyond human hearing. Will discovers that everything on our planet creates its own ...

Credit: Johnson & Johnson. The approval of Spravato for the monotherapy indication in TRD was supported by data from the randomized, double-blind, placebo-controlled, phase 4 TRD4005 trial.

Spravato is classified as a Schedule III controlled substance and is only available through a restricted program called the Spravato REMS. The Food and Drug Administration (FDA) has approved ...

Already on its way to becoming a blockbuster drug, Johnson & Johnson’s Spravato has received another potential boost as the FDA has blessed the nasal spray to be used as a monotherapy for major ...

Please provide your email address to receive an email when new articles are posted on . Spravato is the first monotherapy for adults with major depressive disorder who had an inadequate response ...

Johnson & Johnson's Spravato has been approved to treat a major depressive disorder in adults who have had an inadequate response to at least two oral antidepressants, the FDA announced Tuesday.

"SPRAVATO ® is now available as a standalone treatment, meaning patients may experience improvements in depressive symptoms as early as 24 hours and at 28 days – without the need for daily oral ...